GSA Capital Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-29,214
| Closed | -$1.9M | – | 1663 |
|
|
2022
Q2 | $1.9M | Buy |
+29,214
| New | +$1.9M | 0.29% | 17 |
|
|
2020
Q4 | – | Sell |
-3,263
| Closed | -$285K | – | 1362 |
|
|
2020
Q3 | $285K | Buy |
+3,263
| New | +$285K | 0.05% | 774 |
|
|
2020
Q1 | – | Sell |
-2,529
| Closed | -$291K | – | 1248 |
|
|
2019
Q4 | $291K | Sell |
2,529
-618
| -20% | -$71.1K | 0.03% | 1049 |
|
|
2019
Q3 | $397K | Buy |
+3,147
| New | +$397K | 0.05% | 695 |
|
|
2019
Q2 | – | Sell |
-8,856
| Closed | -$775K | – | 1549 |
|
|
2019
Q1 | $775K | Sell |
8,856
-5,889
| -40% | -$515K | 0.08% | 436 |
|
|
2018
Q4 | $1.48M | Sell |
14,745
-1,362
| -8% | -$136K | 0.17% | 105 |
|
|
2018
Q3 | $1.85M | Sell |
16,107
-42,834
| -73% | -$4.91M | 0.1% | 280 |
|
|
2018
Q2 | $5.29M | Buy |
58,941
+47,254
| +404% | +$4.24M | 0.26% | 23 |
|
|
2018
Q1 | $855K | Buy |
+11,687
| New | +$855K | 0.05% | 763 |
|
|
2017
Q4 | – | Sell |
-44,210
| Closed | -$1.98M | – | 1652 |
|
|
2017
Q3 | $1.98M | Buy |
44,210
+34,953
| +378% | +$1.57M | 0.14% | 158 |
|
|
2017
Q2 | $366K | Buy |
+9,257
| New | +$366K | 0.02% | 1166 |
|
|
2016
Q1 | – | Sell |
-17,326
| Closed | -$559K | – | 1770 |
|
|
2015
Q4 | $559K | Sell |
17,326
-5,899
| -25% | -$190K | 0.03% | 1093 |
|
|
2015
Q3 | $751K | Buy |
23,225
+5,571
| +32% | +$180K | 0.04% | 861 |
|
|
2015
Q2 | $730K | Buy |
17,654
+1,928
| +12% | +$79.7K | 0.03% | 1121 |
|
|
2015
Q1 | $706K | Buy |
15,726
+8,700
| +124% | +$391K | 0.03% | 1153 |
|
|
2014
Q4 | $263K | Buy |
+7,026
| New | +$263K | 0.02% | 1337 |
|